EUVIMEDEUVIMED entdecken
Crossref

Survival of patients with recurrent uveal melanoma after treatment with radiation therapy

Anne M Lane iD, Caleb Hartley, Ashley K Go, Frances Wu, Evangelos S Gragoudas, Ivana K Kim

British Journal of Ophthalmology · 2024

DOI: 10.1136/bjo-2022-323133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift British Journal of Ophthalmology, 2024. Verfasst von Anne M Lane und 5 weiteren Autor:innen. Beteiligte Einrichtung: Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA alane@meei.harvard.edu. Hauptthemen laut MEDLINE: Melanoma, Uveal Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/aims We evaluated a large cohort of patients treated for local recurrence of choroidal or ciliary body melanomas at the Massachusetts Eye and Ear (MEE) to quantify the risk of melanoma-related mortality associated with recurrence, independent of other risk factors.

Methods

Patients treated with radiation therapy from 1982 to 2017 were identified through the Uveal Melanoma Registry at MEE. Competing risks regression was performed to investigate the risk of melanoma-related mortality associated with recurrence, treating recurrence as a time-varying covariate.

Results

Of 4196 patients treated, 4043 patients remained recurrence-free and 153 patients experienced a recurrence (median follow-up: 9.9 years). Median time from initial treatment to recurrence was 30.5 months (range: 2.0–238.7). Seventy-nine (69.9%) patients with recurrences and 826 (37.9%) patients in the recurrence-free group died of metastatic uveal melanoma (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MelanomaUveal NeoplasmsNeoplasm Recurrence, LocalHumansMaleFemaleMiddle AgedAgedAdultRetrospective StudiesSurvival RateFollow-Up StudiesRisk FactorsRegistriesAged, 80 and overYoung AdultUveal Melanoma

Stichwörter der Autor:innen

ChoroidNeoplasia

Autor:innen und Institutionen

  • Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA alane@meei.harvard.edu.
  • Ocular Melanoma Center, Retina Service, Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, USA.

ORCID-Profile: Anne M Lane

Zitieren

APA

Lane, A. M., Hartley, C., Go, A. K., Wu, F., Gragoudas, E. S., & Kim, I. K. (2024). Survival of patients with recurrent uveal melanoma after treatment with radiation therapy. British Journal of Ophthalmology. https://doi.org/10.1136/bjo-2022-323133

Vancouver

Lane AM, Hartley C, Go AK, Wu F, Gragoudas ES, Kim IK. Survival of patients with recurrent uveal melanoma after treatment with radiation therapy. British Journal of Ophthalmology. 2024. doi:10.1136/bjo-2022-323133

BibTeX
@article{Lane2024,
  author = {Lane, Anne M and Hartley, Caleb and Go, Ashley K and Wu, Frances and Gragoudas, Evangelos S and Kim, Ivana K},
  title = {Survival of patients with recurrent uveal melanoma after treatment with radiation therapy},
  journal = {British Journal of Ophthalmology},
  year = {2024},
  doi = {10.1136/bjo-2022-323133}
}
Kostenlos starten →